<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02508220</url>
  </required_header>
  <id_info>
    <org_study_id>Uni-Reg-Oxy-Tin</org_study_id>
    <nct_id>NCT02508220</nct_id>
  </id_info>
  <brief_title>Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus</brief_title>
  <official_title>Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Berthold Langguth, MD, Ph.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Otosul -Otorrinolaringologia Sul-Fluminense</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Regensburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study compares the short-term tinnitus reduction following a single oxytocin intervention
      with a placebo control condition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of tinnitus on VAS</measure>
    <time_frame>30 minutes after intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Clinical global impression scale</measure>
    <time_frame>30 minutes after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Audiometry measured in dB HL</measure>
    <time_frame>within one hour before intervention</time_frame>
    <description>measured in dB HL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimum Masking Level measured in dB HL</measure>
    <time_frame>within one hour before intervention</time_frame>
    <description>measured in dB HL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tinnitus Matching</measure>
    <time_frame>within one hour before intervention</time_frame>
    <description>Frequency measured in Hz</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Chronic Tinnitus</condition>
  <arm_group>
    <arm_group_label>Oxy-Placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Syntocinon first, Placebo second 2 puffs in each nostril</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo-Oxy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Placebo first, Syntocinon second 2 puffs in each nostril</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Syntocinon</intervention_name>
    <description>Oxytocin nasal spray</description>
    <arm_group_label>Oxy-Placebo</arm_group_label>
    <arm_group_label>Placebo-Oxy</arm_group_label>
    <other_name>Oxytocin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>distilled water in nasal spray</description>
    <arm_group_label>Oxy-Placebo</arm_group_label>
    <arm_group_label>Placebo-Oxy</arm_group_label>
    <other_name>distilled water</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic tinnitus with a duration &gt; 6 months

          -  medical examination by an ENT specialist

          -  sufficient knowledge of the Portuguese language to follow the instructions and answer
             the questionnaires

          -  VAS score &gt;4 points

        Exclusion Criteria:

          -  vascular tinnitus

          -  muscular tinnitus

          -  conductive hearing loss

          -  previous experience with oxytocin nasal spray

          -  additional medications during the intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2015</study_first_submitted>
  <study_first_submitted_qc>July 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2015</study_first_posted>
  <last_update_submitted>November 30, 2015</last_update_submitted>
  <last_update_submitted_qc>November 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Regensburg</investigator_affiliation>
    <investigator_full_name>Berthold Langguth, MD, Ph.D.</investigator_full_name>
    <investigator_title>Chair of the Tinnitus centrum Regensburg</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

